Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes? by Joely Kaufman-Janette, Sue Ellen Cox, Steven Dayan, John Joseph

Get full text

High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice by Sabrina Guillen Fabi, Jean Carruthers, John Joseph, Sue Ellen Cox, Steve Yoelin, Julius Few, Joely Kaufman-Janette, Steven Dayan

Get full text

Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials by Lawrence S. Bass, MD, Joely Kaufman-Janette, MD, John H. Joseph, MD, Michael S. Kaminer, MD, James Clark, MD, Sabrina G. Fabi, MD, Michael H. Gold, MD, Bruce E. Katz, MD, Kappa Peddy, MD, Joel Schlessinger, MD, V. Leroy Young, MD, David Hurley, MD, Michael P. McLane, PhD, Saji Vijayan, MBBS, DDiab, Genzhou Liu, PhD, Matthew W. Davis, MD, RPh, Mitchel P. Goldman, MD

Get full text